Blood-Based Test Can Predict Risk of Developing Symptoms of Alzheimer’s Up to a Decade Early
On Jul. 15, 2026, an international study involving researchers across three continents and led by experts from the…
-
-
Alzheimer’s proteins in blood linked to midlife cognition
On Jul. 1, 2026, the National Institutes of Health (NIH) reported that a study found that people in…
-
Blood Test Predicts Dementia in Women as Many as 25 Years Before Symptoms Begin
On Mar. 10, 2026, researchers from the University of California San Diego have found that a novel blood-based…
-
Early signs of Parkinson’s can be identified in the blood
On Jan. 29, 2026, a team led by researchers at Chalmers University of Technology and Oslo University Hospital,…
-
Noninvasive imaging could replace finger pricks for people with diabetes
On Dec. 3, 2025, Massachusetts Institute of Technology (MIT) engineers announced they can accurately measure blood glucose by…
-
CSL injects $2.3b into US for valuable blood plasma
On Nov. 18, 2025, CSL, Australia’s largest biotech company announced plans to expand its US presence with a…
-
Steady glucose-monitor use helps blood-sugar control
On Nov. 5, 2025, a large study of adults with type 2 diabetes showed that those who consistently…
-
Biotechnology | Diagnostics | Disease | FDA | Neurology | NIH
Alzheimer’s Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
On Oct. 13, 2025, the U.S. Food and Drug Administration (FDA) announces it has cleared the Elecsys pTau181…
-
New lab-grown human embryo model produces blood cells
On Oct. 13, 2025, University of Cambridge scientists announced they have used human stem cells to create three-dimensional…
-
First human transplant of kidney modified to have ‘universal’ blood type
On Oct. 3, 2025, scientists have converted the blood type of a donor kidney and transplanted the organ…
-
Rapid bedside test predicts sepsis with over 90 percent accuracy
On May 27, 2025, Canadian scientists announced they have developed a blood test and portable device that can…
-
Researchers discover new blood group system – MAL
On Sept. 16, 2024, researchers from the National Health Service Blood and Transplant (Bristol), NHSBT’s International Blood Group…
-
Abbott received FDA clearance for first commercially available lab-based blood test to help evaluate concussion
On Mar. 7, 2023, Abbott announced that it had received U.S. Food and Drug Administration clearance for what…
-
Blood test for Alzheimer’s highly accurate in large, international study
On Feb. 22, 2022, Washington University in St. Louis announced that a blood test developed at the University’s…
-
U.S. blood donations declared safe under current COVID-19 screening guidelines
On Jun. 1, 2021, a study by researchers at the National Institutes of Health and their colleagues found…
-
NIH launched last phase 3 clinical trial to evaluate safety and effectiveness of blood thinners in adults with COVID-19
On Mar. 8, 2021, the National Institutes of Health (NIH) announced that it had launched the last of…
-
A common blood test identified which COVID-19 patients benefit and which are harmed from steroid treatment
On Jul. 22, 2020, a study led by Albert Einstein College of Medicine and Montefiore Health System confirmed…
-
PerkinElmer released new dried blood spot based COVID-19 serology test
On Jul. 21, 2020, PerkinElmer announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2…
-
Biotechnology | Diagnostics | Neurology | NIH
Neurofilament light chain outperformed other blood tests to predict and diagnose traumatic brain injury
On Jul. 8, 2020, a study from the National Institutes of Health (NIH) showed that neurofilament light chain…
-
NIH scientists developed blood test to help improve liver cancer screening
On Jun. 11, 2020, scientists at the National Cancer Institute (NCI) announced they have developed a new test…
-
Cerus announced FDA approval for INTERCEPT Blood System for plasma with alternate plastic disposable kits
On May 4, 2020, Cerus announced U.S. Food and Drug Administration (FDA) regulatory approval for manufacture of INTERCEPT…
-
XBiotech identified ‘super bloods’ for development of True Human COVID-19 therapy
On May 1, 2020, XBiotech announced that human immune donors have now been identified that can support the Company’s…
-
InBios obtained BARDA funding to develop point-of-care COVID-19 test
On Apr. 30, 2020, InBios announced that it had been awarded a contract from the Biomedical Advanced Research…
-
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Neurology
FDA authorized marketing of first diagnostic test for detecting Zika virus antibodies
On May 23, 2019, the U.S. Food and Drug Administration (FDA) authorized marketing of a diagnostic test to…
-
Sanofi acquired Bioverativ for $11.6 billion
On Mar. 8, 2018, Sanofi acquired Waltham, Massachusetts-based Bioverativ for for $11.6 billion. Bioverativ’s extended half-life therapies, Eloctate…
-
The Foundation for Blood Research closed its doors
On Jun. 30, 2016, the Foundation for Blood Research, a small, independent and nonprofit blood laboratory that served…
-
Biotechnology | Diagnostics | FDA | HIV
The FDA approved the first test for HIV antigen screening of blood donors
On Mar. 14, 1996, the U.S. Food and Drug Administration (FDA) announced the approval of the first antigen…
-
Biotechnology | FDA | HIV
The FDA approved the first test for HIV antbody screening of blood donors
On Mar. 2, 1985, the U.S. Food and Drug Administration (FDA) announced the approval of the Abbott first antibody…
-
Biology | Biotechnology | FDA | NIH | Vaccine
Regulation of Biologics–including serums, vaccines, and blood products–was transferred from NIH to FDA
On Jul. 1, 1972, the Regulation of Biologics–including serums, vaccines, and blood products–was transferred from the NIH to…
-
The Red Cross called for a national blood policy
In 1972, the Red Cross called for a national blood policy to support standardized practices and end paid…
